Anti-TNFα agents: ulcerative colitis or Crohn's disease

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2019年 / 1763卷 / 1期
关键词：
D O I：
10.1007/s40278-019-65099-5
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：7 / 7
相关论文
共 50 条
  • [1] Anti-TNF agents in Crohn's disease
    Van Assche, G
    Rutgeerts, P
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (01) : 103 - 111
  • [2] Identifying Anti-TNF Use for Crohn's Disease and Ulcerative Colitis in Primary Care
    Maguire, Andrew
    Puelles, Jorge
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 518 - 519
  • [3] Anti-TNF therapy use in pregnant patients with Crohn's disease and ulcerative colitis
    Kiely, C.
    Subramaniam, K.
    Pavli, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 104 - 104
  • [4] An Update on Anti-TNF Agents in Ulcerative Colitis
    Samaan, Mark A.
    Bagi, Preet
    Vande Casteele, Niels
    D'Haens, Geert R.
    Levesque, Barrett G.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2014, 43 (03) : 479 - +
  • [5] Differences in biologic efficacy and dose-escalation among anti-TNF agents in Crohn's disease and ulcerative colitis
    Echarri', A.
    Lopez-Casado, P.
    Fraga, R.
    Ollero, V.
    Garcia-Dieguez, L.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S283 - S283
  • [6] Use of Anti-TNFα Agents and Time to First-time Surgery in Paediatric Patients with Ulcerative Colitis and Crohn's Disease
    Larsen, Michael Due
    Qvist, Niels
    Nielsen, Jan
    Kjeldsen, Jens
    Nielsen, Rasmus Gaardskaer
    Norgard, Bente Mertz
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (06): : 650 - 656
  • [7] Increased risk of developing Crohn's disease or ulcerative colitis while being treated with anti-TNFα
    Lyon, Sue
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2019, 80 (08) : 428 - 428
  • [8] Comparison of the durability of response to subcutaneous anti-TNF therapy between ulcerative colitis and Crohn's disease
    Mellotte, G.
    McShane, C.
    O'Connell, J.
    Mc Kiernan, S.
    Mac Carthy, F.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S328 - S328
  • [9] COMPARISON OF THE DURABILITY OF SUBCUTANEOUS ANTI-TNF THERAPY RESPONSE BETWEEN ULCERATIVE COLITIS AND CROHN'S DISEASE
    McShane, Catherine
    Mellotte, Gregory S.
    O'Connell, Jim W.
    Mc Kiernan, Susan
    MacCarthy, Finbar
    Kevans, David
    GASTROENTEROLOGY, 2017, 152 (05) : S587 - S588
  • [10] Surgery for Crohn's disease and anti-TNF agents: the changing scenario
    Sorrentino, Dario
    Fogel, Sandy
    Van den Bogaerde, Johan
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 7 (08) : 689 - 700
12345